Argan is trading at $372.46, down 4.03%, amid broad market weakness after hotter-than-expected September inflation intensified rate-hike concerns.

  • Annual headline inflation was 3.7%, versus a 3.6% forecast; core inflation reached 2.6%, versus 2.5% expected.
  • Reuters reported U.S. stocks opened lower as rate-hike bets increased; supplied index declines also point to broader market pressure.
  • Available reports identified no clear company-specific catalyst for Argan. Intraday volume information was not provided.